AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Lumosa Therapeutics Co., Ltd.

TWD 75.2 -$112.80 (-60.00%)
TWO · 15 Sep 2026 05:30 UTC
Previous Close
TWD 75.8
Day Range
TWD 75.2TWD 76.6
Year Range
TWD 73.7TWD 329.5
Market Cap
12.59B
AVG Volume
263.91K
Trailing/Forward PE
-33.72/-
PEG ratio
2.67
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
Taipei ExchangeTW
Revenue (TWD)
05M10M15M20M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO Revenue (TWD) by quarter
PeriodRevenue (TWD)
26 Q25.13M
26 Q14.48M
25 Q413.05M
25 Q311.71M
25 Q22.18M
25 Q18.9M
24 Q419.81M
24 Q36.37M
24 Q28.52M
24 Q14.46M
Net Income (TWD)
-300M-200M-100M0100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO Net Income (TWD) by quarter
PeriodNet Income (TWD)
26 Q2-161.93M
26 Q1-119.69M
25 Q4-55.63M
25 Q3-32.81M
25 Q2-147.92M
25 Q1-104.19M
24 Q4-148.5M
24 Q3-227.99M
24 Q267.32M
24 Q1-115.62M
Operating Income (TWD)
-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO Operating Income (TWD) by quarter
PeriodOperating Income (TWD)
26 Q2-121.02M
26 Q1-66.5M
25 Q4-43.46M
25 Q3-72.42M
25 Q2-111.21M
25 Q1-106.42M
24 Q4-115.29M
24 Q3-87.83M
24 Q2-73.11M
24 Q1-80.72M
EBITDA (TWD)
-300M-200M-100M0100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO EBITDA (TWD) by quarter
PeriodEBITDA (TWD)
26 Q2-118.26M
26 Q1-63.74M
25 Q4-41.28M
25 Q3-31.34M
25 Q2-147.07M
25 Q1-102.55M
24 Q4-151.38M
24 Q3-229.21M
24 Q267.8M
24 Q1-115.45M
Cash Flows (TWD)
-200M-150M-100M-50M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO Cash Flows (TWD) by quarter
PeriodCash Flows (TWD)
26 Q2-112.64M
26 Q1-51.86M
25 Q4-42.42M
25 Q3-50.7M
25 Q2-186.99M
25 Q1-81.04M
24 Q4-100.23M
24 Q3-51.78M
24 Q2-65.07M
24 Q1-79.69M
EPS (TWD)
-1.5-1-0.500.524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO EPS (TWD) by quarter
PeriodEPS (TWD)
26 Q2-0.97
26 Q1-0.72
25 Q4-0.34
25 Q3-0.2
25 Q2-0.89
25 Q1-0.63
24 Q4-0.9
24 Q3-1.4
24 Q20.41
24 Q1-0.71
Expenses (TWD)
050M100M150MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO Expenses (TWD) by quarter
PeriodExpenses (TWD)
26 Q2122.61M
26 Q166.92M
25 Q450.78M
25 Q379.9M
25 Q2113.72M
25 Q1111.61M
24 Q4123.83M
24 Q390.58M
24 Q278.59M
24 Q182.1M
Cash & Debt (TWD)
0500M1B1.5BCashShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO Cash & Debt (TWD) by quarter
PeriodCash & Debt (TWD)
26 Q2633M
26 Q1747.43M
25 Q4798.34M
25 Q3840.48M
25 Q21.03B
25 Q11.27B
24 Q41.35B
24 Q3555.62M
24 Q2609.05M
24 Q1670.77M
Debt ratios
0123424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO Debt ratios by quarter
PeriodDebt ratios
26 Q22.47
26 Q12.62
25 Q42.46
25 Q31.92
25 Q21.61
25 Q13.03
24 Q43.14
24 Q31.4
24 Q22.16
24 Q11.34
Margins
0%25%50%75%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO Margins by quarter
PeriodMargins
26 Q230.98%
26 Q140.55%
25 Q456.37%
25 Q363.93%
25 Q284.59%
25 Q158.34%
24 Q443.15%
24 Q343.26%
24 Q259.1%
24 Q130.9%
Return on Capital
-20%-10%0%10%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO Return on Capital by quarter
PeriodReturn on Capital
26 Q2-13%
26 Q1-8.53%
25 Q4-3.66%
25 Q3-2.05%
25 Q2-9.08%
25 Q1-5.7%
24 Q4-7.7%
24 Q3-19.4%
24 Q24.83%
24 Q1-8.76%
Shares Outstanding
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2166.1M
26 Q1166.23M
25 Q4165.32M
25 Q3164.04M
25 Q2166.2M
25 Q1165.37M
24 Q4164.75M
24 Q3162.85M
24 Q2164.2M
24 Q1162.82M
Book Value Per Share (TWD)
05101524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO Book Value Per Share (TWD) by quarter
PeriodBook Value Per Share (TWD)
26 Q27.5
26 Q18.44
25 Q49.19
25 Q39.77
25 Q29.8
25 Q111.06
24 Q411.7
24 Q37.22
24 Q28.48
24 Q18.1
Total Assets (TWD)
01B2B3B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
6535.TWO Total Assets (TWD) by quarter
PeriodTotal Assets (TWD)
26 Q21.37B
26 Q11.53B
25 Q41.65B
25 Q31.73B
25 Q21.75B
25 Q12.05B
24 Q42.13B
24 Q31.38B
24 Q21.6B
24 Q11.52B
PE Ratio
020406080med 54.59Dec 21Jan 22Mar 22Apr 22Apr 22May 22Jun 22
6535.TWO PE Ratio by quarter
PeriodPE Ratio
Jun 2257.93
Jun 2257.36
Jun 2257.12
Jun 2255.08
May 2254.59
May 2254.76
May 2254.59
May 2256.87
Apr 2258.01
Apr 2264.1
Apr 2257.04
Apr 2256.3
Apr 2256.55
Mar 2215.81
Mar 2215.81
Mar 2215.7
Mar 2216.71
Feb 2217.3
Feb 2217.42
Feb 2217.57
Jan 2217.44
Jan 2217.01
Jan 2216.95
Jan 2217.44
Dec 2117.95
Free Cash Flow Yield
-3%-2%-1%0%med -1.24%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
6535.TWO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-2.63%
Sep 26-2.65%
Sep 26-2.51%
Aug 26-2.54%
Aug 26-2.47%
Aug 26-2.32%
Aug 26-2.19%
Jul 26-2.3%
Jul 26-2.22%
Jul 26-2.21%
Jul 26-1.99%
Jul 26-1.86%
Jun 26-2.25%
Jun 26-2.12%
Jun 26-2.04%
Jun 26-1.9%
May 26-1.79%
May 26-1.71%
May 26-1.66%
May 26-1.61%
Apr 26-1.44%
Apr 26-1.75%
Apr 26-1.67%
Apr 26-1.57%
Apr 26-1.53%
Mar 26-1.77%
Mar 26-1.76%
Mar 26-1.69%
Mar 26-1.63%
Feb 26-1.48%
Feb 26-1.43%
Feb 26-1.32%
Jan 26-1.46%
Jan 26-1.42%
Jan 26-1.38%
Jan 26-1.36%
Jan 26-1.36%
Dec 25-1.33%
Dec 25-1.38%
Dec 25-1.34%
Dec 25-1.32%
Nov 25-1.16%
Nov 25-1.4%
Nov 25-1.34%
Nov 25-1.26%
Oct 25-1.2%
Oct 25-0.91%
Oct 25-0.87%
Oct 25-0.93%
Oct 25-0.86%
Sep 25-0.63%
Sep 25-0.58%
Sep 25-0.63%
Sep 25-0.74%
Aug 25-0.94%
Aug 25-0.92%
Aug 25-1.06%
Aug 25-1.27%
Aug 25-1.42%
Jul 25-1.33%
Jul 25-1.31%
Jul 25-1.29%
Jul 25-1.27%
Jun 25-1.19%
Jun 25-1.19%
Jun 25-1.1%
Jun 25-1.03%
May 25-1.11%
May 25-1.1%
May 25-1.23%
May 25-1.15%
May 25-1.08%
Apr 25-1.15%
Apr 25-1.15%
Apr 25-1.17%
Apr 25-1.01%
Mar 25-0.89%
Mar 25-0.8%
Mar 25-0.85%
Mar 25-0.74%
Feb 25-0.74%
Feb 25-0.71%
Feb 25-0.68%
Feb 25-0.65%
Jan 25-0.71%
Jan 25-0.71%
Jan 25-0.67%
Jan 25-0.71%
Dec 24-0.87%
Dec 24-0.92%
Dec 24-0.97%
Dec 24-0.84%
Nov 24-0.5%
Nov 24-0.51%
Nov 24-0.53%
Nov 24-0.52%
Nov 24-0.5%
Oct 24-0.47%
Oct 24-0.57%
Oct 24-0.59%
Price to Sales
250500750100012501500med 691.78Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
6535.TWO Price to Sales by quarter
PeriodPrice to Sales
Sep 26401.06
Sep 26398.94
Sep 26421.69
Aug 26415.87
Aug 26428.04
Aug 26455.55
Aug 26482.01
Jul 26460.32
Jul 26476.72
Jul 26477.25
Jul 26531.74
Jul 26568.78
Jun 26447.54
Jun 26475.23
Jun 26493.68
Jun 26530.59
May 26562.89
May 26588.27
May 26609.03
May 26627.48
Apr 26701.31
Apr 26576.73
Apr 26604.41
Apr 26641.33
Apr 26657.47
Mar 26556.6
Mar 26558.52
Mar 26581.63
Mar 26602.82
Feb 26666.38
Feb 26689.49
Feb 26745.34
Jan 26676
Jan 26691.41
Jan 26714.52
Jan 26724.15
Jan 26724.15
Dec 25849.93
Dec 25818.7
Dec 25841
Dec 25856.62
Nov 25970.39
Nov 25803.08
Nov 25843.24
Nov 25896.77
Oct 25936.93
Oct 251244.78
Oct 251293.85
Oct 251209.08
Oct 251311.7
Sep 251085.12
Sep 251183.77
Sep 251083.22
Sep 25918.18
Aug 25724.68
Aug 25747.44
Aug 25646.9
Aug 25538.77
Aug 25481.85
Jul 25514.1
Jul 25521.69
Jul 25531.18
Jul 25536.87
Jun 25637.45
Jun 25639.56
Jun 25692.15
Jun 25734.23
May 25681.63
May 25690.05
May 25618.52
May 25660.6
May 25700.57
Apr 25660.6
Apr 25656.39
Apr 25645.87
Apr 25746.85
Mar 25813.94
Mar 25900.07
Mar 25848.39
Mar 25979.74
Feb 25979.74
Feb 251012.04
Feb 251059.41
Feb 251113.24
Jan 251020.65
Jan 251022.81
Jan 251087.4
Jan 251016.35
Dec 24714.11
Dec 24676.26
Dec 24643.56
Dec 24736.48
Nov 241242.39
Nov 241214.85
Nov 241164.95
Nov 241204.53
Nov 241244.11
Oct 241316.38
Oct 241094.4
Oct 241049.66
EV/EBITDA
10203040med 29.25Dec 21Jan 22Mar 22Apr 22Apr 22May 22Jun 22
6535.TWO EV/EBITDA by quarter
PeriodEV/EBITDA
Jun 2231.71
Jun 2231.29
Jun 2231.11
Jun 2229.61
May 2229.25
May 2229.37
May 2229.25
May 2230.93
Apr 2231.77
Apr 2236.28
Apr 2231.05
Apr 2230.51
Apr 2230.69
Mar 2210.76
Mar 2210.76
Mar 2210.66
Mar 2211.57
Feb 2212.12
Feb 2212.22
Feb 2212.36
Jan 2212.24
Jan 2211.85
Jan 2211.79
Jan 2212.24
Dec 2112.71
Price to Book
01020304050med 17.49Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
6535.TWO Price to Book by quarter
PeriodPrice to Book
Sep 268.98
Sep 268.93
Sep 269.44
Aug 269.31
Aug 269.58
Aug 2610.2
Aug 2610.79
Jul 2610.3
Jul 2610.67
Jul 2610.68
Jul 2611.9
Jul 2612.73
Jun 2610.56
Jun 2611.21
Jun 2611.64
Jun 2612.51
May 2613.28
May 2613.87
May 2614.36
May 2614.8
Apr 2616.54
Apr 2613.6
Apr 2614.26
Apr 2615.13
Apr 2615.51
Mar 2614.79
Mar 2614.84
Mar 2615.46
Mar 2616.02
Feb 2617.71
Feb 2618.32
Feb 2619.81
Jan 2617.96
Jan 2618.37
Jan 2618.99
Jan 2619.24
Jan 2619.24
Dec 2519.43
Dec 2518.72
Dec 2519.23
Dec 2519.59
Nov 2522.19
Nov 2518.36
Nov 2519.28
Nov 2520.51
Oct 2521.42
Oct 2528.46
Oct 2529.59
Oct 2527.65
Oct 2529.99
Sep 2525.87
Sep 2528.22
Sep 2525.82
Sep 2521.89
Aug 2517.28
Aug 2517.82
Aug 2515.42
Aug 2512.84
Aug 2511.49
Jul 2512.26
Jul 2512.44
Jul 2512.66
Jul 2512.8
Jun 2512.95
Jun 2512.99
Jun 2514.06
Jun 2514.91
May 2513.85
May 2514.02
May 2512.56
May 2513.42
May 2514.23
Apr 2513.42
Apr 2513.33
Apr 2513.12
Apr 2515.17
Mar 2526.19
Mar 2528.96
Mar 2527.3
Mar 2531.52
Feb 2531.52
Feb 2532.56
Feb 2534.09
Feb 2535.82
Jan 2532.84
Jan 2532.91
Jan 2534.99
Jan 2532.7
Dec 2424.47
Dec 2423.17
Dec 2422.05
Dec 2425.23
Nov 2442.57
Nov 2441.62
Nov 2439.91
Nov 2441.27
Nov 2442.63
Oct 2445.1
Oct 2437.5
Oct 2435.96
Lumosa Therapeutics Co., Ltd.
6535.TWO
Stockpicker

Video analysis: 6535.TWO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.